Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $18,364 | 1,017 | 99.3% |
| Education | $131.59 | 4 | 0.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $2,365 | 148 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $2,271 | 118 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $2,229 | 156 | $0 (2024) |
| GlaxoSmithKline, LLC. | $1,501 | 64 | $0 (2024) |
| Amarin Pharma Inc. | $1,202 | 71 | $0 (2023) |
| Amgen Inc. | $1,075 | 42 | $0 (2024) |
| Lilly USA, LLC | $786.00 | 48 | $0 (2024) |
| PFIZER INC. | $639.58 | 41 | $0 (2024) |
| NESTLE HEALTHCARE NUTRITION INC. | $596.11 | 31 | $0 (2023) |
| Merck Sharp & Dohme LLC | $470.93 | 17 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,724 | 134 | AstraZeneca Pharmaceuticals LP ($707.69) |
| 2023 | $2,732 | 139 | ABBVIE INC. ($483.45) |
| 2022 | $2,486 | 139 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($506.59) |
| 2021 | $3,304 | 201 | AbbVie Inc. ($534.61) |
| 2020 | $2,426 | 144 | AstraZeneca Pharmaceuticals LP ($397.67) |
| 2019 | $1,959 | 111 | Amgen Inc. ($328.89) |
| 2018 | $1,654 | 83 | Amarin Pharma Inc. ($258.87) |
| 2017 | $1,211 | 70 | GlaxoSmithKline, LLC. ($288.58) |
All Payment Transactions
1,021 individual payment records from CMS Open Payments — Page 1 of 41
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/31/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $18.27 | General |
| Category: Gastroenterology | ||||||
| 12/31/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $16.41 | General |
| Category: Gastroenterology | ||||||
| 12/18/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $27.52 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/18/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $12.56 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/16/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $23.33 | General |
| Category: Inflammation | ||||||
| 12/10/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $28.27 | General |
| Category: Diabetes | ||||||
| 12/10/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $19.89 | General |
| Category: Gastroenterology | ||||||
| 12/04/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $20.25 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 12/03/2024 | PFIZER INC. | PAXLOVID (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $21.06 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 11/26/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $27.78 | General |
| Category: RESPIRATORY | ||||||
| 11/20/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $26.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/20/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $19.86 | General |
| Category: Gastroenterology | ||||||
| 11/13/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $121.25 | General |
| Category: RESPIRATORY | ||||||
| 11/13/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $19.98 | General |
| Category: Respiratory | ||||||
| 11/12/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $22.13 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/06/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $9.11 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/04/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $25.02 | General |
| Category: Diabetes | ||||||
| 11/04/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: Respiratory | ||||||
| 11/04/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $18.49 | General |
| Category: Cardio-renal | ||||||
| 10/31/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $18.53 | General |
| Category: Respiratory | ||||||
| 10/30/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $23.30 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/23/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $18.35 | General |
| Category: Endocrinology | ||||||
| 10/22/2024 | SCILEX PHARMACEUTICALS INC. | ZTLido (Drug) | Food and Beverage | In-kind items and services | $23.10 | General |
| Category: Analgesic | ||||||
| 10/15/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $18.49 | General |
| Category: Cardio-renal | ||||||
| 10/14/2024 | ABBVIE INC. | CREON (Drug) | Food and Beverage | In-kind items and services | $18.37 | General |
| Category: ENDOCRINOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 27 | 1,968 | 6,863 | $785,640 | $381,897 |
| 2022 | 28 | 2,053 | 6,904 | $958,808 | $401,164 |
| 2021 | 34 | 2,109 | 7,277 | $576,627 | $411,706 |
| 2020 | 35 | 1,943 | 5,703 | $369,926 | $279,104 |
All Medicare Procedures & Services
124 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 457 | 3,800 | $596,602 | $297,837 | 49.9% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 57 | 363 | $39,203 | $20,791 | 53.0% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 33 | 145 | $35,956 | $8,837 | 24.6% |
| 76700 | Complete ultrasound scan of abdomen | Office | 2023 | 79 | 80 | $16,640 | $8,514 | 51.2% |
| 76536 | Ultrasound scan of head and neck soft tissue | Office | 2023 | 62 | 62 | $12,400 | $6,428 | 51.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 36 | 36 | $10,440 | $5,269 | 50.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 322 | 601 | $7,814 | $5,032 | 64.4% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 124 | 381 | $17,275 | $4,884 | 28.3% |
| 76775 | Limited ultrasound scan behind abdominal cavity | Office | 2023 | 66 | 66 | $6,930 | $3,643 | 52.6% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 47 | 54 | $5,346 | $2,814 | 52.6% |
| G0179 | Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 2023 | 57 | 69 | $5,037 | $2,675 | 53.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 16 | 16 | $3,568 | $2,384 | 66.8% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 131 | 153 | $6,882 | $1,902 | 27.6% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 18 | 27 | $3,159 | $1,684 | 53.3% |
| 76770 | Complete ultrasound scan behind abdominal cavity | Office | 2023 | 18 | 18 | $3,474 | $1,659 | 47.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 44 | 44 | $2,640 | $1,583 | 60.0% |
| 98928 | Osteopathic manipulative treatment, 7-8 body regions | Office | 2023 | 11 | 23 | $2,806 | $1,502 | 53.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 13 | 13 | $2,873 | $1,290 | 44.9% |
| 90688 | Influenza vaccine, quadrivalent, 0.5 ml dosage | Office | 2023 | 44 | 44 | $2,162 | $899.46 | 41.6% |
| 99406 | Smoking and tobacco use intensive counseling, 4-10 minutes | Office | 2023 | 15 | 31 | $1,198 | $532.89 | 44.5% |
| 81002 | Urinalysis, manual test | Office | 2023 | 101 | 141 | $846.00 | $480.81 | 56.8% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2023 | 96 | 322 | $998.20 | $392.69 | 39.3% |
| G0446 | Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes | Office | 2023 | 11 | 11 | $495.00 | $331.32 | 66.9% |
| 87880 | Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | Office | 2023 | 19 | 20 | $500.00 | $324.00 | 64.8% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 29 | 152 | $243.20 | $129.73 | 53.3% |
About Rena Khanukayeva
Rena Khanukayeva is a Family Medicine healthcare provider based in Staten Island, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/16/2006. The National Provider Identifier (NPI) number assigned to this provider is 1255358164.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Rena Khanukayeva has received a total of $18,496 in payments from pharmaceutical and medical device companies, with $2,724 received in 2024. These payments were reported across 1,021 transactions from 59 companies. The most common payment nature is "Food and Beverage" ($18,364).
As a Medicare-enrolled provider, Khanukayeva has provided services to 8,073 Medicare beneficiaries, totaling 26,747 services with total Medicare billing of $1.5M. Data is available for 4 years (2020–2023), covering 124 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Staten Island, NY
- Active Since 07/16/2006
- Last Updated 09/24/2024
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1255358164
Products in Payments
- XIFAXAN (Drug) $1,624
- FARXIGA (Drug) $1,364
- Vascepa (Drug) $1,202
- ZENPEP (Drug) $826.65
- TRELEGY ELLIPTA (Drug) $703.47
- UBRELVY (Drug) $644.18
- LINZESS (Drug) $583.27
- TRULANCE (Drug) $520.85
- Aimovig (Biological) $509.58
- BREZTRI (Drug) $460.47
- VRAYLAR (Drug) $368.70
- NEXLETOL (Drug) $365.80
- JARDIANCE (Drug) $330.69
- TRULICITY (Drug) $325.95
- ANORO (Drug) $297.04
- TRINTELLIX (Drug) $284.14
- Otezla (Drug) $268.14
- Kerendia (Drug) $254.28
- SYMBICORT (Drug) $242.11
- CREON (Drug) $238.33
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Staten Island
Dr. Sean Fenton, Do, DO
Family Medicine — Payments: $151,500
Dr. Joseph Buono, Md, MD
Family Medicine — Payments: $17,313
Dr. Arthur Sigelman, M.d, M.D
Family Medicine — Payments: $16,837
Dr. Neil Nepola, Mdpc, MDPC
Family Medicine — Payments: $16,239
Dr. Tatyana Katsman, D.o, D.O
Family Medicine — Payments: $11,356
Dr. Tauqeer Ahmad, Md, MD
Family Medicine — Payments: $4,099